Literature DB >> 15496977

Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma.

M J Borad, R Swift, J R Berenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15496977     DOI: 10.1038/sj.leu.2403541

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

Review 1.  Arsenic trioxide - An old drug rediscovered.

Authors:  Ashkan Emadi; Steven D Gore
Journal:  Blood Rev       Date:  2010-05-15       Impact factor: 8.250

Review 2.  New frontiers in the treatment of multiple myeloma.

Authors:  Janice Jin Hwang; Irene M Ghobrial; Kenneth C Anderson
Journal:  ScientificWorldJournal       Date:  2006-12-06

Review 3.  Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review.

Authors:  Xuepeng He; Kai Yang; Peng Chen; Bing Liu; Yuan Zhang; Fang Wang; Zhi Guo; Xiaodong Liu; Jinxing Lou; Huiren Chen
Journal:  Onco Targets Ther       Date:  2014-09-10       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.